Author

Marie Hudson

McGill University - Cited by 14,969

Biography

Dr Marie Hudson is working as a researcher at McGill University, Canada. His research program has two axes: (1) systemic autoimmune rheumatic diseases, and (2) immune-related adverse events (irAE) secondary to cancer immunotherapies.
Title
Cited by
Year
Trial of intravenous immune globulin in dermatomyositis
R Aggarwal, C Charles-Schoeman, J Schessl, Z Bata-Csörgő, ...New England Journal of Medicine 387 (14), 1264-1278, 2022202
39
2022
Barriers and facilitators to physical activity for people with scleroderma: A scleroderma patient‐Centered Intervention Network Cohort Study
S Harb, S Peláez, ME Carrier, L Kwakkenbos, SJ Bartlett, M Hudson, ...Arthritis Care & Research 74 (8), 1300-1310, 2022202
11
2022
COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis
R Naveen, I Parodis, M Joshi, P Sen, J Lindblom, V Agarwal, JB Lilleker, ...Rheumatology 2 (7), 23-237, 2023202
6
2023
Exposure to silica and systemic sclerosis: a retrospective cohort study based on the Canadian Scleroderma Research Group
A Muntyanu, R Milan, E Rahme, A LaChance, L Ouchene, M Cormier, ...Frontiers in Medicine 9, 984907, 2022202
5
2022
Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis
B Ellezam, V Leclair, Y Troyanov, I Bersali, M Giannini, S Hoa, ...Neuropathology and Applied Neurobiology 8 (7), e1280, 2022202
4
2022
Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program
L Kwakkenbos, N Østbø, ME Carrier, WR Nielson, C Fedoruk, B Levis, ...Pilot and Feasibility Studies 8 (1), 1-15, 2022202
4
2022
Damage Trajectories in Systemic Sclerosis Using Group‐Based Trajectory Modeling
A Barbacki, M Baron, M Wang, Y Zhang, W Stevens, J Sahhar, ...Arthritis Care & Research 75 (3), 60-67, 2023202
4
2023
Effects of a support group leader education program jointly developed by health professionals and patients on peer leader self-efficacy among leaders of scleroderma support …
BD Thombs, B Levis, ME Carrier, L Dyas, J Nordlund, L Tao, K Aguila, ...Orphanet Journal of Rare Diseases 17 (1), 1-15, 2022202
3
2022
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
M Tonneau, A Nolin-Lapalme, S Kazandjian, E Auclin, J Panasci, ...Oncoimmunology 11 (1), 096535, 0
2
2022
Glucosamine and lower mortality and cancer incidence: selection bias in the observational studies
K Suissa, M Hudson, S SuissaPharmacoepidemiology and Drug Safety 31 (1), 17-179, 0
2
2022
Pain in autoimmune inflammatory myopathies: a scoping review
V Leclair, H Tsui, M HudsonRMD open 9 (1), e00591, 030
2
2023
Geographical distribution of systemic sclerosis in Canada: An ecologic study based on the Canadian Scleroderma Research Group
A Muntyanu, L Ouchene, S Zhou, M Hudson, M Rezaeian, A LaChance, ...Journal of the American Academy of Dermatology 87 (5), 1095-1097, 0
2
2022
State-of-the-art evidence in the treatment of systemic sclerosis
JE Pope, CP Denton, SR Johnson, A Fernandez-Codina, M Hudson, ...Nature Reviews Rheumatology 19 (4), 1-6, 030
2
2023
Screening and management of subclinical interstitial lung disease in systemic sclerosis: an international survey
S Hoa, M Baron, M HudsonRheumatology 61 (8), 3401-3407, 0
2
2022
External validation of a shortened screening tool using individual participant data meta-analysis: A case study of the Patient Health Questionnaire-Dep-4
D Harel, B Levis, Y Sun, F Fischer, JPA Ioannidis, P Cuijpers, SB Patten, ...Methods 04, 300-311, 0
2
2022
Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered …
L Kwakkenbos, ME Carrier, J Welling, B Levis, AW Levis, M Sauve, ...Trials 23 (), -5, 2022202
1
2022
Myositis with prominent B-cell aggregates causing shrinking lung syndrome in systemic lupus erythematosus: a case report
F Roy, P Korathanakhun, J Karamchandani, BP Dubé, ...BMC rheumatology 6 (), -6, 2022202
1
2022
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group
N Ghosh, N Couette, WH van Binsbergen, SC Weinmann, B Jivanelli, ...Seminars in Arthritis and Rheumatism, 520, 2022202
1
2022
Measuring the impact of mylupusguide in canada: results of a randomized controlled study
PR Fortin, C Neville, AS Julien, E Rahme, V Haroun, J Nimigon‐Young, ...Arthritis Care & Research 75 (3), 529-539, 2023202
1
2023
High Frequency of COVID-19 Vaccine Hesitancy among Canadians Immunized for Influenza: A Cross-Sectional Survey
High Frequency of COVID-9 Vaccine Hesitancy among Canadians Immunized for Influenza: A Cross-Sectional SurveyV Valerio, E Rampakakis, TP Zanos, TJ Levy, HC Shen, EG McDonald, ...Vaccines 0 (9), 54, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=wc9i4AQAAAAJ&hl=en

Cited by
Citations 14969
h-index 69
i10-index 249
Recommended Journals
Open Access Journals